The Golden Triangle Partnership, representing networking organisations in Cambridge, London and Oxford, has announced the signing of an agreement with BIOCOM.
France’s small biopharmaceutical and life science companies have been weakened by the financial crisis and had to face a drastic drop in investment in 2009.
The £3.5 billion a year currently spent on publicly-funded research generates an annual output of £45 billion in UK companies, according to a new report.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.